Filing Flows › Precigen (PGEN) › Q2 2025
Precigen (PGEN) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Precigen (PGEN) reported revenue of $856K for the second quarter 2025 (Q2 2025) and -36% from the quarter before.
Precigen, Q2 2025: revenue $856K, net loss $26.6M, operating cash flow −$19.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $856K | -36% | — |
| Operating profit | −$31.8M | — | — |
| Net earnings | −$26.6M | — | — |
| Operating cash flow | −$19.0M | — | — |
What changed
Revenue was $856K in Q2 2025, down 36% from the previous quarter.
Operating costs exceeded revenue by $31.8M, an operating margin of -3710.7%. The quarter ended with a net loss of $26.6M, narrower than the previous quarter's $54.2M loss.
Operating cash flow was −$19.0M. Non-cash charges added back $630K of depreciation and amortization and $1.6M of share-based compensation. Working capital and other items added $5.4M. Capital expenditures of $1.0M exceeded it, leaving free cash flow of −$19.9M.
Questions
What was Precigen's revenue in the second quarter 2025?
Precigen (PGEN) reported revenue of $856K for the second quarter 2025 (Q2 2025) and -36% from the quarter before.
Source: Precigen 10-Q on SEC EDGAR.